Press "Enter" to skip to content

Oncocyte Shares Tank on News of Delayed CLIA Validation Study for Liquid Biopsy Lung Cancer Test – GenomeWeb

admin 0

Oncocyte Shares Tank on News of Delayed CLIA Validation Study for Liquid Biopsy Lung Cancer Test  GenomeWeb

NEW YORK – OncoCyte’s shares fell nearly 29 percent to $ 2.85 in Wednesday morning trading on the Nasdaq after the company announced that it will need …

“lung cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *